Lizette Utomo

Dr. Lizette Utomo

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

13 January 2015 in Biomedical Materials
Verified
Journal Article
Closed access
LULizette Utomo
Lizette Utomo
MPMieke M Pleumeekers
Mieke M Pleumeekers
LNLuc Nimeskern
Luc Nimeskern
SNSylvia Nürnberger
Sylvia Nürnberger
KSKathryn S Stok
Kathryn S Stok
GOGerjo J V M van Osch
Gerjo J V M van Osch
Scaffolds are widely used to reconstruct cartilage. Yet, the fabrication of a scaffold with a highly organized microenvironment that closely resembles native cartilage remains a major challenge. Scaffolds derived from acellular extracellular matrices are able to provide such a microenvironment. Currently, no report specifically on decellularization of full thickness ear cartilage has been published. In this study, decellularized ear cartilage scaffolds were prepared and extensively characterized. Cartilage decellularization was optimized to remove cells and cell remnants from elastic cartilage. Following removal of nuclear material, the obtained scaffolds retained their native collagen and elastin contents as well as their architecture and shape. High magnification scanning electron microscopy showed no obvious difference in matrix density after decellularization. However, glycosaminoglycan content was significantly reduced, resulting in a loss of viscoelastic properties. Additionally, in contact with the scaffolds, human bone-marrow-derived mesenchymal stem cells remained viable and are able to differentiate toward the chondrogenic lineage when cultured in vitro . These results, including the ability to decellularize whole human ears, highlight the clinical potential of decellularization as an improved cartilage reconstruction strategy.

12 August 2019 in Advanced Healthcare Materials
Verified
Journal Article
Open access
PDF file
BKBarbara J. Klotz
Barbara J. Klotz
LOLoes A. Oosterhoff
Loes A. Oosterhoff
LULizette Utomo
Lizette Utomo
Khoon LimKhoon Lim
Khoon Lim
QVQueralt Vallmajo‐Martin
Queralt Vallmajo‐Martin
DGDebby Gawlitta
Debby Gawlitta
For creating functional tissue analogues in tissue engineering, stem cells require very specific 3D microenvironments to thrive and mature. Demanding (stem) cell types that are used nowadays can find such an environment in a heterogeneous protein mixture with the trade name Matrigel. Several variations of synthetic hydrogel platforms composed of poly(ethylene glycol) (PEG), which are spiked with peptides, have been recently developed and shown equivalence to Matrigel for stem cell differentiation. Here a clinically relevant hydrogel platform, based on PEG and gelatin, which even outperforms Matrigel when targeting 3D prevascularized bone and liver organoid tissue engineering models is presented. The hybrid hydrogel with natural and synthetic components stimulates efficient cell differentiation, superior to Matrigel models. Furthermore, the strength of this hydrogel lies in the option to covalently incorporate unmodified proteins. These results demonstrate how a hybrid hydrogel platform with intermediate biological complexity, when compared to existing biological materials and synthetic PEG‐peptide approaches, can efficiently support tissue development from human primary cells.

1 September 2016 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
LULizette Utomo
Lizette Utomo
GOGerjo J.V.M. Van Osch
Gerjo J.V.M. Van Osch
YBYves Bayon
Yves Bayon
JVJ.A.N. Verhaar
J.A.N. Verhaar
YBY.M. Bastiaansen-Jenniskens
Y.M. Bastiaansen-Jenniskens

1 February 2016 in Journal of Biomechanics
Verified
Journal Article
Closed access
LNLuc Nimeskern
Luc Nimeskern
LULizette Utomo
Lizette Utomo
ILIina Lehtoviita
Iina Lehtoviita
GFGion Fessel
Gion Fessel
JSJess G. Snedeker
Jess G. Snedeker
KSKathryn S. Stok
Kathryn S. Stok

21 February 2020 in European Cells and Materials
Verified
Journal Article
Closed access
ALA Longoni
A Longoni
LULizette Utomo
Lizette Utomo
IHIem van Hooijdonk
Iem van Hooijdonk
GBGkp Bittermann
Gkp Bittermann
VVVc Vetter
Vc Vetter
DGD Gawlitta
D Gawlitta
Dental pulp stem cells (DPSCs) are particularly promising for tissue engineering (TE) due to the ease of their isolation procedure, great expansion potential and capability to differentiate towards several cell types of the mesodermal, ectodermal and endodermal lineages. Although several studies hint that DPSCs exhibit potential for cartilage tissue formation, the chondrogenic potential of DPSCs has only been marginally explored. Thus, the aim of the present study was to closely investigate the chondrogenic differentiation capacity of DPSCs for TE applications. More specifically, the potential of DPSCs for engineering hyaline and fibrous cartilage was determined. DPSCs obtained from 7 human molars were expanded and chondrogenically differentiated in a 3D pellet culture model. After 21 d of differentiation with chondrogenic stimuli, DPSCs displayed glycosaminoglycan, aggrecan and limited collagen type II deposition. Cells presented an elongated morphology and produced a collagen-rich extracellular matrix, with a predominance of collagen type I in most of the samples, a characteristic of fibrous cartilage tissue. Variations in the administration periods of several chondro-inductive growth factors, including transforming growth factor beta 3, bone morphogenetic protein-2, -6, -7 and insulin-like growth factor-1, did not increase glycosaminoglycan or collagen type II deposition, typical markers of hyaline cartilage tissue. Furthermore, DPSCs could not be stimulated to go into hypertrophic chondrogenesis. These results indicated that under a large variety of chondro-inductive culture conditions, DPSCs could form fibrocartilaginous tissues but not hyaline cartilage. Thus, DPSCs represent a valuable cell source for the regeneration of fibrocartilage in joints.